ProfileOfResearchers

TÃTULO: Immunohistochemical versus molecular (BluePrint and MammaPrint) subtyping of breast carcinoma. Outcome results from the EORTC 10041/BIG 3-04 MINDACT trial Full Text
AUTORES: Viale, G; de Snoo, FA; Slaets, L; Bogaerts, J; van 't Veer, L; Rutgers, EJ; Piccart Gebhart, MJ; Stork Sloots, L; Glas, A; Russo, L; Dell'Orto, P; Tryfonidis, K; Litiere, S; Cardoso, F;
PUBLICAÇÃO: 2018, FONTE: BREAST CANCER RESEARCH AND TREATMENT, VOLUME: 167, NÚMERO: 1

INDEXADO EM:

Scopus

WOS

TÃTULO: Male breast cancer precursor lesions: analysis of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program
AUTORES: Shusma C Doebar; Leen Slaets; Fatima Cardoso; Sharon H Giordano; John M S Bartlett; Konstantinos Tryfonidis; Nizet H Dijkstra; Caroline P Schroder; Christi J van Asperen; Barbro Linderholm; Kim Benstead; Winan N M Dinjens; Ronald van Marion; Paul J van Diest; John W M Martens; Carolien H M van Deurzen;
PUBLICAÇÃO: 2017, FONTE: MODERN PATHOLOGY, VOLUME: 30, NÚMERO: 4

INDEXADO EM:

WOS

TÃTULO: Not all small node negative (pT1abN0) breast cancers are similar: Outcome results from an EORTC 10041/BIG 3-04 (MINDACT) trial substudy
AUTORES: Tryfonidis, K; Poncet, C; Slaets, L; Viale, G; de Snoo, F; Aalders, K; Van 't Veer, L; Rutgers, E; Piccart, M; Bogaerts, J; Cardoso, F;
PUBLICAÇÃO: 2017, FONTE: 42nd European-Society-for-Medical-Oncology Congress (ESMO) in ANNALS OF ONCOLOGY, VOLUME: 28

INDEXADO EM:

WOS

TÃTULO: Pathologic prognostic factors of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABG International Male Breast Cancer Program Full Text
AUTORES: Vermeulen, MA; Slaets, L; Cardoso, F; Giordano, S; Aebi, S; Bayani, J; Van Diest, PJ; Fraser, J; Goulioti, T; Kelly, C; Van Leeuwen Stok, E; Linderholm, B; Martens, J; Peeters, S; Porter, P; Rubio, I; Schroder, C; Tryfonidis, K; Bartlett, JMS; Van Deurzen, CHM;
PUBLICAÇÃO: 2016, FONTE: EUROPEAN JOURNAL OF CANCER, VOLUME: 57

INDEXADO EM:

WOS

TÃTULO: Characterization of male breast cancer: First results of the EORTC10085/TBCRC/BIG/NABCG International Male BC Program
AUTORES: Fatima Cardoso; John Bartlett; Leen Slaets; Carolien van Deurzen; Elise van Leewen Stok; Peggy Porter; Barbro Linderholm; Ingrid Hedenfalk; Carolien Schroder; John Martens; Jane Bayani; Christi van Asperen; Melissa Murray; Clifford Hudis; Lavinia Middleton; Joanna Vermeij; Stephanie Peeters; Judith Fraser; Monica Nowaczyk; Isabel Rubio; Stefan Aebi; Catherine Kelly; Kathryn Ruddy; Eric Winer; Cecilia Nilsson; Lissandra Dal Lago; Larissa Korde; Kim Benstead; Danielle Van Den Weyngaert; Oliver Bogler; Theodora Goulioti; Nicolas Dif; Carlo Messina; Konstantinos Tryfonidis; Jan Bogaerts; Sharon Giordano; ...Mais
PUBLICAÇÃO: 2015, FONTE: 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium in CANCER RESEARCH, VOLUME: 75, NÚMERO: 9

INDEXADO EM:

WOS

TÃTULO: Are all small tumors low risk? Characterization of small invasive node negative breast cancers (BC) enrolled in the EORTC 10041/BIG 3-04 (MINDACT) trial
AUTORES: Giuseppe Viale; Femke Snoo; Laura Van't Veer; Emiel Rutgers; Martine Piccart; Jan Bogaerts; Fatima Cardoso; Konstantinos Tryfonidis; Leen Slaets;
PUBLICAÇÃO: 2015, FONTE: 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium in CANCER RESEARCH, VOLUME: 75, NÚMERO: 9

INDEXADO EM:

WOS

TÃTULO: Pathological assessment of discordant cases for molecular (BluePrint and MammaPrint) vs clinical subtypes for breast cancer, among 6,694 patients from the EORTC 10041/BIG 3-04 (MINDACT) trial
AUTORES: Giuseppe Viale; Leen Slaets; Femke A de Snoo; Jan Bogaerts; Laura J van't Veer; Emiel J Rutgers; Martine J Piccart Gebhart; Jeroen van den Akker; Lisette Stork Sloots; Leila Russo; Patrizia Dell'Orto; Fatima Cardoso;
PUBLICAÇÃO: 2015, FONTE: 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium in CANCER RESEARCH, VOLUME: 75, NÚMERO: 9

INDEXADO EM:

WOS

TÃTULO: High concordance of protein (by IHC), gene (by FISH; HER2 only), and microarray readout (by TargetPrint) of ER, PgR, and HER2: results from the EORTC 10041/BIG 03-04 MINDACT trial
AUTORES: Viale, G; Slaets, L; Bogaerts, J; Rutgers, E; van't Veer, L; Piccart Gebhart, MJ; de Snoo, FA; Stork Sloots, L; Russo, L; Dell'Orto, P; van den Akker, J; Glas, A; Cardoso, F;
PUBLICAÇÃO: 2014, FONTE: ANNALS OF ONCOLOGY, VOLUME: 25, NÚMERO: 4

INDEXADO EM:

Scopus

WOS

TÃTULO: Comparison of molecular (BluePrint plus MammaPrint) and pathological subtypes for breast cancer among the first 800 patients from the EORTC 10041/BIG3-04 (MINDACT) trial
AUTORES: Giuseppe Viale; Leen Slaets; Femke De Snoo; Laura J van 't Veer; Emiel J Rutgers; Martine J Piccart Gebhart; Jan Bogaerts; Jeroen van den Akker; Kristel Engelen; Leila Russo; Patrizia Dell'Orto; Fatima Cardoso;
PUBLICAÇÃO: 2012, FONTE: 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 30, NÚMERO: 15

INDEXADO EM:

WOS

TÃTULO: Comparison of molecular (BluePrint and MammaPrint) and pathological subtypes for breast cancer among the first 800 patients from the EORTC 10041/BIG 3-04 (MINDACT) trial.
AUTORES: Giuseppe Viale; Leen Slaets; Femke De Snoo; Laura J van 't Veer; Emiel J Rutgers; Jan Bogaerts; Lisette Stork Sloots; Kristel Engelen; Leila Russo; Patrizia Dell'Orto; Fatima Cardoso; Martine J Piccart Gebhart;
PUBLICAÇÃO: 2012, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 30, NÚMERO: 27

INDEXADO EM:

WOS

Links Úteis